Principal Investigator
Xia Shengli, PhD
Henan Center for Disease Control and Prevention
Total Trials
1
As PI
1
Completed
1
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
BIOLOGICAL(1)
MIXED(1)
15μg H7N9 Vaccine
1 trial
phase_2
shanghai-institute-of-biological-productsAluminum Hydroxide Adjuvant
1 trial
phase_2
shanghai-institute-of-biological-products2 unique interventions2 categories
Analytics
Trial Phases
Phase 21
Trial Status
Completed1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine
H7N9 Influenza
PrincipalinvestigatorStart date: 2018-11-10
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Henan Center for Disease Control and Prevention
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
3 similar investigators found
Novartis vaccines and Diagnostics
Novartis Vaccines
22 trials
Shared therapeutic areas:
H7N9 Influenza
Similarity Score30%
Esper Kallas, PhD
University of Sao Paulo
1 trials
Shared therapeutic areas:
H7N9 Influenza
Similarity Score30%
Ze Chen, PhD
Shanghai Institute Of Biological Products
1 trials
Shared therapeutic areas:
H7N9 Influenza
Worked with same sponsors:
Shanghai Institute Of Biological Products
Similarity Score30%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine
H7N9 Influenza
All 1 trials loaded